{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:57:25Z","timestamp":1791291445082,"version":"4.3.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T00:00:00Z","timestamp":1322870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s00403-011-1196-y","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T08:19:35Z","timestamp":1322900375000},"page":"203-208","source":"Crossref","is-referenced-by-count":10,"title":["Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis"],"prefix":"10.1007","volume":"304","author":[{"given":"Koichi","family":"Yanaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,3]]},"reference":[{"key":"1196_CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02802301","volume":"12","author":"B Bonavida","year":"1994","unstructured":"Bonavida B, Mencia-Huerta JM (1994) Platelet-activating factor and the cytokine network in inflammatory processes. Clin Rev Allergy 12:381\u2013395","journal-title":"Clin Rev Allergy"},{"key":"1196_CR2","doi-asserted-by":"crossref","first-page":"52425","DOI":"10.1074\/jbc.M410967200","volume":"279","author":"F Bonin","year":"2004","unstructured":"Bonin F, Ryan SD, Migahed L et al (2004) Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I \u03b12 catalytic subunit. J Biol Chem 279:52425\u201352436","journal-title":"J Biol Chem"},{"key":"1196_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-6147(00)88968-3","volume":"16","author":"AR Butler","year":"1995","unstructured":"Butler AR, Flitney FW, Williams DL (1995) NO, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist\u2019s perspective. Trends Pharmacol Sci 16:18\u201322","journal-title":"Trends Pharmacol Sci"},{"key":"1196_CR4","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892\u20131896","journal-title":"J Rheumatol"},{"key":"1196_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4615-4857-7_13","volume":"455","author":"S Generini","year":"1999","unstructured":"Generini S, Matucci Cerinic M (1999) Raynaud\u2019s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 455:93\u2013100","journal-title":"Adv Exp Med Biol"},{"key":"1196_CR6","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.164.6.3360","volume":"164","author":"WR Henderson Jr","year":"2000","unstructured":"Henderson WR Jr, Lu J, Poole KM, Dietsch GN, Chi EY (2000) Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model. J Immunol 164:3360\u20133367","journal-title":"J Immunol"},{"key":"1196_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/ard.51.1.29","volume":"51","author":"P Hilliquin","year":"1992","unstructured":"Hilliquin P, Menkes CJ, Laoussadi S, Benveniste J, Arnoux B (1992) Presence of paf-acether in rheumatic diseases. Ann Rheum Dis 51:29\u201331","journal-title":"Ann Rheum Dis"},{"key":"1196_CR8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0016-5085(98)70096-4","volume":"115","author":"B Hofbauer","year":"1998","unstructured":"Hofbauer B, Saluja AK, Bhatia M et al (1998) Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology 115:1238\u20131247","journal-title":"Gastroenterology"},{"key":"1196_CR9","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbalip.2006.05.008","volume":"1761","author":"SA Karabina","year":"2006","unstructured":"Karabina SA, Ninio E (2006) Plasma PAF-acetylhydrolase: an unfulfilled promise? Biochim Biophys Acta 1761:1351\u20131358","journal-title":"Biochim Biophys Acta"},{"key":"1196_CR10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbalip.2006.06.017","volume":"1761","author":"K Karasawa","year":"2006","unstructured":"Karasawa K (2006) Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 1761:1359\u20131372","journal-title":"Biochim Biophys Acta"},{"key":"1196_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0003-4975(00)01405-3","volume":"70","author":"JD Kim","year":"2000","unstructured":"Kim JD, Baker CJ, Roberts RF et al (2000) Platelet activating factor acetylhydrolase decreases lung reperfusion injury. Ann Thorac Surg 70:423\u2013428","journal-title":"Ann Thorac Surg"},{"key":"1196_CR12","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202\u2013205","journal-title":"J Rheumatol"},{"key":"1196_CR13","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/eji.1830260804","volume":"26","author":"E Lupia","year":"1996","unstructured":"Lupia E, Montrucchio G, Battaglia E, Modena V, Camussi G (1996) Role of tumor necrosis factor-\u03b1 and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Eur J Immunol 26:1690\u20131694","journal-title":"Eur J Immunol"},{"key":"1196_CR14","doi-asserted-by":"crossref","first-page":"32315","DOI":"10.1074\/jbc.272.51.32315","volume":"272","author":"A Matsuzawa","year":"1997","unstructured":"Matsuzawa A, Hattori K, Aoki J, Arai H, Inoue K (1997) Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II. J Biol Chem 272:32315\u201332320","journal-title":"J Biol Chem"},{"key":"1196_CR15","doi-asserted-by":"crossref","first-page":"II365","DOI":"10.1161\/circ.100.suppl_2.Ii-365","volume":"100","author":"EN Morgan","year":"1999","unstructured":"Morgan EN, Boyle EM Jr, Yun W et al (1999) Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury. Circulation 100:II365\u2013II368","journal-title":"Circulation"},{"key":"1196_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(93)70014-K","volume":"28","author":"DF Murrell","year":"1993","unstructured":"Murrell DF (1993) A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28:78\u201385","journal-title":"J Am Acad Dermatol"},{"key":"1196_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1620\/tjem.207.65","volume":"207","author":"H Oshimoto","year":"2005","unstructured":"Oshimoto H, Okamura S, Iida T, Ishikawa T, Hosaka K, Mori M (2005) Diagnostic value of the serum platelet-activating factor acetylhydrolase activity in inflammatory bowel disease. Tohoku J Exp Med 207:65\u201371","journal-title":"Tohoku J Exp Med"},{"key":"1196_CR18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","volume":"343","author":"CJ Packard","year":"2000","unstructured":"Packard CJ, O\u2019Reilly DS, Caslake MJ et al (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343:1148\u20131155","journal-title":"N Engl J Med"},{"key":"1196_CR19","first-page":"1080","volume":"26","author":"I Palacios","year":"1999","unstructured":"Palacios I, Miguelez R, Sanchez-Pernaute O, Gutierrez S, Egido J, Herrero-Beaumont G (1999) A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice. J Rheumatol 26:1080\u20131086","journal-title":"J Rheumatol"},{"key":"1196_CR20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","volume":"69","author":"SM Prescott","year":"2000","unstructured":"Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419\u2013445","journal-title":"Annu Rev Biochem"},{"key":"1196_CR21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.1780370313","volume":"37","author":"S Sato","year":"1994","unstructured":"Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthr Rheum 37:391\u2013394","journal-title":"Arthr Rheum"},{"issue":"Suppl 3","key":"1196_CR22","doi-asserted-by":"crossref","first-page":"iii19","DOI":"10.1093\/rheumatology\/kep105","volume":"48","author":"V Steen","year":"2009","unstructured":"Steen V, Denton CP, Pope JE, Matucci-Cerinic M (2009) Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 48(Suppl 3):iii19\u2013iii24","journal-title":"Rheumatology (Oxford)"},{"key":"1196_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/art.1780310207","volume":"31","author":"VD Steen","year":"1988","unstructured":"Steen VD, Powell DL, Medsger TAJ (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthr Rheum 31:196\u2013203","journal-title":"Arthr Rheum"},{"key":"1196_CR24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthr Rheum 23:581\u2013590","journal-title":"Arthr Rheum"},{"key":"1196_CR25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0008-6363(96)00109-5","volume":"32","author":"M Suematsu","year":"1996","unstructured":"Suematsu M, Wakabayashi Y, Ishimura Y (1996) Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc Res 32:679\u2013686","journal-title":"Cardiovasc Res"},{"key":"1196_CR26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1165\/ajrcmb.19.4.3058","volume":"19","author":"M Tamm","year":"1998","unstructured":"Tamm M, Bihl M, Eickelberg O, Stulz P, Perruchoud AP, Roth M (1998) Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. Am J Respir Cell Mol Biol 19:653\u2013661","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1196_CR27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3","volume":"42","author":"AD Tselepis","year":"1999","unstructured":"Tselepis AD, Elisaf M, Besis S, Karabina SA, Chapman MJ, Siamopoulou A (1999) Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity. Arthr Rheum 42:373\u2013383","journal-title":"Arthr Rheum"},{"key":"1196_CR28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.STR.0000257981.09329.d2","volume":"38","author":"K Umemura","year":"2007","unstructured":"Umemura K, Kato I, Hirashima Y et al (2007) Neuroprotective role of transgenic PAF-acetylhydrolase II in mouse models of focal cerebral ischemia. Stroke 38:1063\u20131068","journal-title":"Stroke"},{"key":"1196_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/09629359791758","volume":"6","author":"P Vergne","year":"1997","unstructured":"Vergne P, Praloran V, Treves R, Denizot Y (1997) Decreased levels of serum platelet-activating factor acetylhydrolase in patients with rheumatic diseases. Mediat Inflamm 6:241\u2013242","journal-title":"Mediat Inflamm"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-011-1196-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1196-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T11:25:45Z","timestamp":1686482745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-011-1196-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s00403-011-1196-y","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,3]]}}}